Jack Dorsey’s claim was labelled an “outright lie” on Twitter by Rajeev Chandrasekhar, Union Minister of State for Electronics & Technology.

OneWeb

Toyota Motor stated it would implement high-performance, solid-state batteries as well as other technologies to increase the efficiency and performance of its electric vehicles while lowering their price.

The Japanese automaker Toyota Motor declared that it plans to introduce next-generation batteries starting in 2026, hoping to win over buyers with cars that have greater driving ranges and faster charging periods.

“MRF’s share price reaches Rs 1 lakh milestone as it opens over 1% higher, backed by impressive Q4 results. The company’s consolidated profit after tax surged 86% YoY, while revenue

Mirae Global

SEBI bars Essel Group Chairman Subhash Chandra and ZEEL CEO Punit Goenka from directorial roles in listed companies. Investigations revealed their misuse of positions to divert funds for personal benefit.

The relationship between China and India has been strained since a violent clash along their shared border in 2020. The recent expulsion of journalists from both countries has further deepened the rift between these Asian economic powerhouses. In a tit-for-tat response, Chinese authorities have asked the last Indian journalist in China to leave, while Indian journalists in China faced visa denials. This article will explore the background, events, and implications of this escalating media standoff.

UBS, the world’s largest wealth manager, announced on Monday that it has successfully completed its emergency takeover of Credit Suisse, a move that creates a giant Swiss bank with a

VW (Volkswagen) AG’s battery arm will uphold the arrangement with a $100 million prepayment for future nickel conveyances, while items merchant Glencore Plc will purchase $100 million of ACG stock.

Amp Energy India, a pioneer in the energy transition and India’s first totally balanced independent power producer (IPP), has raised up to USD 250 million to support its expansion. SMBC

For over a decade, the pharmaceutical industry in India has faced growing concerns regarding the quality and safety of its medicines, both domestically and internationally. This issue is particularly alarming as India’s pharmaceutical sector is a significant contributor to the country’s economy and a major supplier of generic medicines to the global market. In this article, we will delve into the pressing need for improved regulatory standards and enhanced accountability within India’s pharmaceutical industry, emphasizing the detrimental consequences of substandard medicines on patients worldwide.

Chinook Therapeutics, Inc., a biopharmaceutical company specializing in the discovery, development, and commercialization of precision drugs for kidney diseases, today announced that it has entered into a merger agreement and